Bavarian Nordic

Bavarian Nordic Overview

Company Headquarters: Denmark, Europe

Founded: 1992

Workforce: ~1000

Company Working: Bavarian Nordic is a fully integrated vaccines company focused on R&D innovation, vaccine manufacturing, and vaccine commercialization. It has built a commercial infrastructure with a presence in key countries in Europe and the US in order to drive profitable expansion of its expanding vaccine portfolio. The company is an expert in the production of live viral vaccines, and the fill & finish capabilities has enabled end-to-end commercial-scale production

Strategy

Bavarian Nordic unveiled a five-year strategy in 2020. Building on its core strengths in vaccine research, development, and manufacturing, it accelerated its growth through a strategic product acquisition and organizational expansion to include a full, global commercial infrastructure, transforming itself into a full-fledged vaccine company with the goal of becoming one of the largest pure play vaccine companies by 2025, with annual revenues exceeding USD 1 billion

Company Snapshot

$319.66M

Revenue

1,000

Employees

1992

Founded

Denmark, Europe

Headquarters

SWOT Analysis

Strengths

Sate of the art research and development facility
High customer satisfaction
Strategic acquisitions

Weaknesses

High dependency on developed markets
Earnings growth is expected to be slow

Opportunities

Increase R&D expenditure to drive innovations
Expansion into new market after government agreement

Threats

New technological developments by a few competitors within the industry pose a threat to the company
Fluctuations in foreign currency rates

Key Developments

Date	Approach	Development
May 2023	–	Bavarian Nordic announced the completion of its acquisition of Emergent BioSolutions Inc.'s (US) travel vaccination portfolio.
December 2022	–	Bavarian Nordic announced a new agreement with the U.S. Department of Defense’s (DOD) Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) for the advanced development of MVA-BN WEV, a prophylactic vaccine candidate against Western, Eastern, and Venezuelan equine encephalitis virus.
November 2022	–	Bavarian Nordic announced the signing of a cooperative procurement agreement with HERA, the European Commission's Health Emergency Preparedness and Response Authority, for the provision of up to 2 million doses of its MVA-BN monkeypox vaccine in 2023 and 2024.
October 2022	–	Bavarian Nordic announced that the Swiss Federal Office of Public Health and the Swiss Armed Forces had ordered 100,000 doses of MVA-BN smallpox and monkeypox vaccine.
October 2022	–	Bavarian Nordic announced a supply arrangement with a Latin American country for their monkeypox vaccine.
July 2022	–	Bavarian Nordic announced that the European Commission (EC) has extended the marketing authorization for the Company’s smallpox vaccine, IMVANEX to include protection from monkeypox and disease caused by vaccinia virus.

Product Offering

Bavarian Nordic
- Biodefense Market

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.